Discovery of the natural anti‐Gal antibody and its past and future relevance to medicine
Author:
- 12 April 2013
- journal article
- review article
- Published by Wiley in Xenotransplantation
- Vol. 20 (3) , 138-147
Abstract
This is a personal account of the discovery of the natural anti‐Gal antibody, the most abundant natural antibody in humans, the reciprocal distribution of this antibody and its ligand the α‐gal epitope in mammals and the immunological barrier this antibody has formed in porcine to human xenotransplantation. This barrier has been overcome in the recent decade with the generation of α1,3‐galactosyltransferase gene‐knockout pigs. However, anti‐Gal continues to be relevant in medicine as it can be harnessed for various therapeutic effects. Anti‐Gal converts tumor lesions injected with α‐gal glycolipids into vaccines that elicit a protective anti‐tumor immune response by in situ targeting of tumor cells for uptake by antigen‐presenting cells. This antibody further accelerates wound and burn healing by interaction with α‐gal nanoparticles applied to injured areas and induction of rapid recruitment and activation of macrophages. Anti‐Gal/α‐gal nanoparticle immune complexes may further induce rapid recruitment and activation of macrophages in ischemic myocardium and injured nerves, thereby inducing tissue regeneration and prevention of fibrosis.Keywords
This publication has 70 references indexed in Scilit:
- The Life History of 21 Breast CancersCell, 2012
- In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal GlycolipidsCancers, 2010
- Accelerated healing of skin burns by anti-Gal/α-gal liposomes interactionBurns, 2010
- Quantitative analysis by in vivo imaging of the dynamics of vascular and axonal networks in injured mouse spinal cordProceedings of the National Academy of Sciences, 2009
- The cancer genomeNature, 2009
- Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activityCancer Immunology, Immunotherapy, 2009
- Functionally important glycosyltransferase gain and loss during catarrhine primate emergenceProceedings of the National Academy of Sciences, 2007
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Genetically engineered pigsThe Lancet, 1993
- The natural anti‐α‐galactosyl IgG on human normal senescent red blood cellsBritish Journal of Haematology, 1986